Engitix Engitix Therapeutics is a company offering a human extracellular matrix (ECM)-based discovery platform. | ||||
Founding Date | Founding Date 2015 | Founding Date 2016 | Founding Date 2013 | Founding Date 2020 |
Type | Type Private | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations Villigen, CH HQ | Locations Cambridge, US HQ London, GB London, GB | Locations London, GB HQ New York, US New York, US | Locations Boston, US HQ |
Employees | Employees N/A | Employees 542% increase | Employees 19 | Employees 2315% increase |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 6.4m (over 7 years ago) | Latest funding round N/A | Latest funding round $ 6.5m (over 3 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 6.4m | Total funding raised N/A | Total funding raised $ 6.5m |
Engitix Therapeutics is a company offering a human extracellular matrix (ECM)-based discovery platform.
View company
Eleusis is a company developing the therapeutic potential of serotonin 2A receptor agonists.
View company
Nanite is a biotechnology company that develops non-viral gene delivery vehicles.
View company